Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Examines conditions under which index funds tend to outperform active options, with practical implications for portfolio building.
15,084 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Artificial intelligence is reshaping how companies grow and compete. This guide breaks down the two best AI-focused s...
Tech weakness pressured theStreet today, dragging the broader market even as select companies posted government contr...
Nvidia's upcoming earnings could be the turning point for AI stocks. This article breaks down what to watch, possible...
Investors confront a major test coming stock environment as the Fed signals it won’t step in to cushion losses. Morga...
Markets are watching the Fed's next move as rate hikes loom. This guide explains how the pattern of interest rates so...
Gold prices lower investors as tensions with Iran push the dollar higher and crude up, trimming bullion bets as trade...
Prospect Capital offers a striking 20%+ yield, but its long-run performance raises questions. This article lays out a...
Gold and the S&P 500 offer different paths to growth and risk management. This guide explains when should invest gold...
As copper markets gyrate in 2026, investors must choose between COPX miners and CPER futures for exposure. The decisi...
New York’s decision to pause large-scale data center projects up to a year changes the playing field for cloud giants...
In March, oil price declines helped airline stocks rally even as the broader market parsed mixed signals. This articl...